Your browser doesn't support javascript.
loading
Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients.
Panagiota, Victoria; Kerschbaum, Johanna Franziska; Penack, Olaf; Stein, Catarina M; Arends, Christopher M; Koenecke, Christian; Strzelecka, Paulina M; Kloos, Arnold; Wiegand, Laura; Lasch, Alina; Altwasser, Robert; Halik, Adriane; Gabdoulline, Razif; Thomson, Julia; Weibl, Konstantin; Franke, Georg-Nikolaus; Berger, Carolina; Hasenkamp, Justin; Ayuk, Francis; Na, Il-Kang; Beutel, Gernot; Keller, Ulrich; Bullinger, Lars; Wulf, Gerald Georg; Kröger, Nicolaus; Vucinic, Vladan; Heuser, Michael; Damm, Frederik.
Affiliation
  • Panagiota V; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Kerschbaum JF; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany.
  • Penack O; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany.
  • Stein CM; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany.
  • Arends CM; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany.
  • Koenecke C; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany.
  • Strzelecka PM; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Kloos A; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany.
  • Wiegand L; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Lasch A; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany.
  • Altwasser R; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Halik A; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany.
  • Gabdoulline R; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany.
  • Thomson J; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany.
  • Weibl K; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Franke GN; Department of Hematology and Medical Oncology, University Medicine Göttingen, Germany.
  • Berger C; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany.
  • Hasenkamp J; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany.
  • Ayuk F; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Germany.
  • Na IK; Department of Hematology and Medical Oncology, University Medicine Göttingen, Germany.
  • Beutel G; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Germany.
  • Keller U; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany.
  • Bullinger L; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany.
  • Wulf GG; German Cancer Consortium (DKTK), Partner Site Berlin, Germany.
  • Kröger N; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, ECRC Experimental and Clinical Research Center, Berlin, Germany.
  • Vucinic V; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Heuser M; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany.
  • Damm F; German Cancer Consortium (DKTK), Partner Site Berlin, Germany.
Hemasphere ; 7(10): e957, 2023 Oct.
Article in En | MEDLINE | ID: mdl-37799345
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Hemasphere Year: 2023 Document type: Article Affiliation country: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Hemasphere Year: 2023 Document type: Article Affiliation country: Alemania